Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hasselblad

Showing results (191-200 of 250) with videos related to

Pageof 25
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 27, 2007
Relationship between interdialytic weight gain and blood pressure among prevalent hemodialysis patientsJula K Inrig, Uptal D Patel, Barbara S Gillespie, et al.
The American Journal of Cardiology|May 15, 2003
Comparison of 30-day outcome, resource use, and coronary artery disease severity in patients with suspected coronary artery disease with and without diabetes mellitus assigned to chest pain unitsCarlos D Sánchez, L Kristin Newby, Vic Hasselblad, et al.
Circulation|February 11, 2004
Differential treatment benefit of platelet glycoprotein IIb/IIIa inhibition with percutaneous coronary intervention versus medical therapy for acute coronary syndromes: exploration of methodsKaren S Pieper, Anastasios A Tsiatis, Marie Davidian, et al.
The American Journal of Cardiology|March 17, 2004
Effect of angiotensin-converting enzyme inhibitors, beta blockers, statins, and aspirin on C-reactive protein levels in outpatients with heart failureKaren E Joynt, Wendy A Gattis, Vic Hasselblad, et al.
Trials|June 21, 2013
Methods of creatine kinase-MB analysis to predict mortality in patients with myocardial infarction treated with reperfusion therapyRenato D Lopes, Yuliya Lokhnygina, Victor Hasselblad, et al.
American Heart Journal|July 2, 2005
Intensity and focus of heart failure disease management after hospital dischargeMonica R Shah, Carol M Flavell, Joanne R Weintraub, et al.
Circulation|December 22, 1998
Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischemic heart diseaseD F Kong, R M Califf, D P Miller, et al.
Journal of General Internal Medicine|December 8, 2011
Updated report on comparative effectiveness of ACE inhibitors, ARBs, and direct renin inhibitors for patients with essential hypertension: much more data, little new informationBenjamin J Powers, Remy R Coeytaux, Rowena J Dolor, et al.
Pharmacoepidemiology and Drug Safety|May 31, 2026
The Association Between MOG-IgG Positivity and mRNA SARS-CoV-2 Vaccination in Denmark: A Self-Controlled Case Series StudyTine Iskov Kopp, Anne Katrine Andreasen, Viktoria Papp, et al.
Journal of the American College of Cardiology|June 1, 2002
Prognostic significance of elevated troponin I after percutaneous coronary interventionWarren J Cantor, L Kristin Newby, Robert H Christenson, et al.
Pageof 25

Showing results (191-200 of 250) with videos related to

Sort By:
Pageof 25
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 27, 2007
Relationship between interdialytic weight gain and blood pressure among prevalent hemodialysis patientsJula K Inrig, Uptal D Patel, Barbara S Gillespie, et al.
The American Journal of Cardiology|May 15, 2003
Comparison of 30-day outcome, resource use, and coronary artery disease severity in patients with suspected coronary artery disease with and without diabetes mellitus assigned to chest pain unitsCarlos D Sánchez, L Kristin Newby, Vic Hasselblad, et al.
Circulation|February 11, 2004
Differential treatment benefit of platelet glycoprotein IIb/IIIa inhibition with percutaneous coronary intervention versus medical therapy for acute coronary syndromes: exploration of methodsKaren S Pieper, Anastasios A Tsiatis, Marie Davidian, et al.
The American Journal of Cardiology|March 17, 2004
Effect of angiotensin-converting enzyme inhibitors, beta blockers, statins, and aspirin on C-reactive protein levels in outpatients with heart failureKaren E Joynt, Wendy A Gattis, Vic Hasselblad, et al.
Trials|June 21, 2013
Methods of creatine kinase-MB analysis to predict mortality in patients with myocardial infarction treated with reperfusion therapyRenato D Lopes, Yuliya Lokhnygina, Victor Hasselblad, et al.
American Heart Journal|July 2, 2005
Intensity and focus of heart failure disease management after hospital dischargeMonica R Shah, Carol M Flavell, Joanne R Weintraub, et al.
Circulation|December 22, 1998
Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischemic heart diseaseD F Kong, R M Califf, D P Miller, et al.
Journal of General Internal Medicine|December 8, 2011
Updated report on comparative effectiveness of ACE inhibitors, ARBs, and direct renin inhibitors for patients with essential hypertension: much more data, little new informationBenjamin J Powers, Remy R Coeytaux, Rowena J Dolor, et al.
Pharmacoepidemiology and Drug Safety|May 31, 2026
The Association Between MOG-IgG Positivity and mRNA SARS-CoV-2 Vaccination in Denmark: A Self-Controlled Case Series StudyTine Iskov Kopp, Anne Katrine Andreasen, Viktoria Papp, et al.
Journal of the American College of Cardiology|June 1, 2002
Prognostic significance of elevated troponin I after percutaneous coronary interventionWarren J Cantor, L Kristin Newby, Robert H Christenson, et al.
Pageof 25